What is Viemed Healthcare, Inc.'s SG&A?

Viemed Healthcare, Inc. (VMD) reported SG&A of $34.79M in Q1 2026.

How has Viemed Healthcare, Inc.'s SG&A changed year-over-year?

Viemed Healthcare, Inc.'s SG&A increased by 22.4% year-over-year, from $28.43M to $34.79M.

What is the long-term trend for Viemed Healthcare, Inc.'s SG&A?

Over 4 years (2021 to 2025), Viemed Healthcare, Inc.'s SG&A has grown at a 21.9% compound annual growth rate (CAGR), from $54.89M to $121.37M.

Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.

Viemed Healthcare, Inc. VMD SG&A

SG&A at other companies

Evolent Health, Inc.EVH

$72.82M-7.1%

The Pennant Group, Inc.PNTG

$19.69M+32.7%

UFP TechnologiesUFPT

$21.02M+12.3%

Merit Medical SystemsMMSI

$118.21M+10.0%

BrightSpring Health Services, Inc.BTSG

$360.77M+25.4%

SolventumSOLV

$827M+7.5%

Other financials

Income statement

See full

Revenue$75.4M+27.5%

Gross profit$42.8M+28.7%

Operating income$4.3M+11.8%

Net income$2.6M-1.6%

EPS (diluted)$0.060.0%

Balance sheet

See full

Cash & equivalents$9.8M-3.9%

Total debt$12.4M+84.0%

Total equity$143.9M+6.8%

Total assets$197.4M+10.8%

Cash flow

See full

Operating cash flow$8.1M+183%

CapEx$6.7M-56.6%

Free cash flow$1.4M+111%

Valuation

See full

Market cap$448.16M+71.3%

Enterprise value$450.83M+74.6%

P/E30.1×+8.8×

P/S1.6×+0.4×

Profitability

See full

Gross margin57.6%-1.1pp

Operating margin8.2%-0.2pp

Net margin5.2%-0.1pp

FCF margin9%—

Returns & leverage

See full

Return on equity10.7%+0.9pp

Debt / equity0.1×0.0×

Current ratio1.2×-0.2×

Where this comes from

Reported directly by Viemed Healthcare, Inc. in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The official record: Viemed Healthcare, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Viemed Healthcare, Inc.'s sg&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Viemed Healthcare, Inc.'s SG&A?: Viemed Healthcare, Inc. (VMD) reported SG&A of $34.79M in Q1 2026.
How has Viemed Healthcare, Inc.'s SG&A changed year-over-year?: Viemed Healthcare, Inc.'s SG&A increased by 22.4% year-over-year, from $28.43M to $34.79M.
What is the long-term trend for Viemed Healthcare, Inc.'s SG&A?: Over 4 years (2021 to 2025), Viemed Healthcare, Inc.'s SG&A has grown at a 21.9% compound annual growth rate (CAGR), from $54.89M to $121.37M.
What does SG&A mean?: Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.